(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 15.95% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.32%.
Natera's revenue in 2026 is $2,908,873,000.On average, 27 Wall Street analysts forecast NTRA's revenue for 2026 to be $444,003,843,302, with the lowest NTRA revenue forecast at $411,087,817,035, and the highest NTRA revenue forecast at $466,044,530,494. On average, 27 Wall Street analysts forecast NTRA's revenue for 2027 to be $535,066,682,490, with the lowest NTRA revenue forecast at $484,895,118,224, and the highest NTRA revenue forecast at $587,268,310,050.
In 2028, NTRA is forecast to generate $664,410,715,222 in revenue, with the lowest revenue forecast at $551,017,179,800 and the highest revenue forecast at $915,268,536,552.